PROton Therapy for Post Surgical Treatment of GYNecologic Cancer
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This is a single institution, multi-center, Phase II, single-arm study, using Whole Pelvis (WP) Pencil Beam Scanning Proton Radiation (PBS PRT) in the post-surgical, adjuvant setting for definitive treatment of gynecologic cancers. The purpose of this study is to estimate rate of acute clinician-reported gastrointestinal (GI) toxicity using WP PBS PRT in the definitive treatment of gynecologic cancers in the post-surgical, adjuvant setting.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Potwierdzony rozpoznaniem rak szyjki macicy lub endometrium
- •Kwalifikacja do radioterapii całej miednicy po operacji
- •Wiek 18 lat lub więcej
- •Wyrażona pisemna zgoda na uczestnictwo
- •Ogólny stan zdrowia pozwalający na podjęcie leczenia
✗ Disqualifies
- •Poprzednia radioterapia miednicy
- •Przerzuty nowotworu poza miednicę
- •Aktywne zapalenie jelita grubego
- •Niezdolność do wyrażenia świadomej zgody
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- September 17, 2026
- Sex
- Female only
Therapies / drugs in trial
Locations (3)
Virtua Health
Voorhees Township, United States
Lancaster General Health - Ann B. Barshinger Cancer Institute
Lancaster, United States
University of Pennsylvania
Philadelphia, United States
Trial contact
Project Manager
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/18/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.